Article · 30 Dec 2025
ArticlePublished 2 Sep 2020
HIF1 PFKFB3 pathway is a novel mechanism to account for slow cell loss and cell dysfunction in type2 diabetes
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The islet in Type 2 diabetes (T2D) is characterized by β-cell dysfunction and amyloid deposits from the islet amyloid polypeptide (IAPP), a protein co-secreted with insulin by β-cells. We established that hIAPP toxicity activates the conserved hypoxia inducible factor 1 α (HIF1α) injury repair pathway that remodels the metabolism via its target, the phosphofructokinase PFKFB3, recapitulating the metabolic phenotype of β-cells in T2D. The main adaptive metabolic response relies on the disengagement of glycolysis from the mitochondrial TCA cycle along with adaptive fragmentation of the mitochondrial network. In the presence of maintained mitochondrial membrane potential, the fragmented mitochondrial network provides a protectiveposture from the stress-induced increase in cytosolic Ca2+. Silencing of PFKFB3 in β-cells expressing hIAPP toxic oligomers rescues mitochondrial form, relative metabolite composition and glucose-dependent compartment Ca2+increase, butfailstorescuepyruvateanaplerosis, indicatingthat PFKFB3 iscentraltothe β-cell metabolic reprogramming in stress. Conditional disruption of PFKFB3 in mouse β-cells heterozygous for hIAPP (which don’t develop diabetes spontaneously) facilitates onset of diabetes under high fat diet, indicating that metabolic remodeling by PFKFB3 is important for the survival of β-cells under hIAPP stress. Given the unique dependence of β-cell function on the tight engagement of glucose with the TCA cycle, this pro-survival change in metabolism predictably induces β-cell dysfunction with relatively high insulin secretion occurring at baseline glucose and a deficient response to glucose stimulation, both characteristics of β-cells in T2D. Moreover, in contrast to tissues with the capacity to regenerate, β-cells in adult humans are minimally replicative and therefore fail to execute the pro-regenerative phase of the HIF1α injury repair. Instead, β-cells in T2D remain trapped in the first phase of the HIF1α injury repair response with pro-survival metabolism that slows down the rate of cell attrition at the expense of β-cell function.
Subjects
Diabetes & EndocrinologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Diabetes Medication & Care.
Article · 30 Dec 2025
Drug-Drug Interactions in Diabetes: Ensuring Safe and Effective Therapy
Article · 30 Dec 2025
Insulin Resistance Modulators: Targeting the Root of Metabolic Dysfunction
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Diabetes Medication & Care
- SubjectDiabetes & Endocrinology
- BylineArticles whose byline prints “Slavica Tudzarova”
- BylineArticles whose byline prints “Chiara Montemurro”
- BylineArticles whose byline prints “Hiroshi Nomoto”
- BylineArticles whose byline prints “Lina Pei”
- BylineArticles whose byline prints “Vishal Parekh”
- BylineArticles whose byline prints “Kenny Vongbunyong”
- BylineArticles whose byline prints “Suryakiran Vadrevu”
- BylineArticles whose byline prints “Tatyana Gurlo”